Dare Bioscience Inc

DARE

Company Profile

  • Business description

    Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

  • Contact

    3655 Nobel Drive
    Suite 260
    San DiegoCA92122
    USA

    T: +1 858 926-7655

    E: [email protected]

    https://www.darebioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    24

Stocks News & Analysis

stocks

Overvalued ASX share has overly ambitious profit target

We think the new profit target is aggressive and unlikely to be met.
stocks

7 undervalued US stocks that crushed earnings

Arista and GE Vernova remain among the cheapest Morningstar-covered stocks after strong earnings beats.
stocks

Undervalued ASX share hitting on all cylinders

Strong performance across all segments in latest earnings release.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,018.50146.90-1.60%
CAC 408,352.0016.91-0.20%
DAX 4026,598.64151.31-0.57%
Dow JONES (US)51,608.17739.38-1.41%
FTSE 10010,881.5521.01-0.19%
HKSE23,458.96294.88-1.24%
NASDAQ24,509.76626.52-2.49%
Nikkei 22558,935.99726.03-1.22%
NZX 50 Index14,307.633.860.03%
S&P 5007,416.59145.08-1.92%
S&P/ASX 2008,902.60142.10-1.57%
SSE Composite Index3,578.2624.31-0.67%

Market Movers